Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 232-188-7 | CAS number: 7789-75-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The results of studies of repeated dose oral toxicity indicate that calcium fluoride exhibits typical fluoride toxicity, however the low water solubility of the substance indicates that the oral bioavailability of fluoride from the substance is less than other salts such as sodium fluoride, thereby limiting its toxicity.
Key value for chemical safety assessment
- Toxic effect type:
- dose-dependent
Repeated dose toxicity: via oral route - systemic effects
Link to relevant study records
- Endpoint:
- short-term repeated dose toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: NTP study
- Qualifier:
- according to guideline
- Guideline:
- other: NTP protocol
- Principles of method if other than guideline:
- 6-month repeated dose study.
- GLP compliance:
- not specified
- Limit test:
- no
- Species:
- mouse
- Strain:
- B6C3F1
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Progeny of C57BL/N6 female and C3H/HeN male mice, obtained from Charles River Laboratories, Wilmington, DE, were used in this study. Mice were 4 to 6 weeks old when placed on study. Their diet consisted of a semisynthetic low fluoride diet. The mice were kept in groups of ten in cages set at a temperture of 22-24 degC and of relative humidity 40-60%. The fluorescent light was 12 hours per day.
- Route of administration:
- oral: drinking water
- Vehicle:
- water
- Details on oral exposure:
- Groups of 8-12 mice of each sex received 0, 10, 30, 100, 200, 300 or 600 ppm sodium fluoride in deionised water ad libitum for 6 months.
- Analytical verification of doses or concentrations:
- no
- Details on analytical verification of doses or concentrations:
- The concentrations are nominal concentrations.
- Duration of treatment / exposure:
- 0, 10, 50, 100, 200, 300 or 600 ppm sodium fluoride in deionised water
- Frequency of treatment:
- Continuous (ad libitum, in drinking water)
- Dose / conc.:
- 0 ppm
- Remarks:
- Concentration of NaF in drinking water.
- Dose / conc.:
- 10 ppm
- Remarks:
- Concentration of NaF in drinking water.
- Dose / conc.:
- 50 ppm
- Remarks:
- Concentration of NaF in drinking water.
- Dose / conc.:
- 100 ppm
- Remarks:
- Concentration of NaF in drinking water.
- Dose / conc.:
- 200 ppm
- Remarks:
- Concentration of NaF in drinking water.
- Dose / conc.:
- 300 ppm
- Remarks:
- Concentration of NaF in drinking water.
- Dose / conc.:
- 600 ppm
- Remarks:
- Concentration of NaF in drinking water.
- No. of animals per sex per dose:
- The method stated ten mice of each sex per dose group. However, some of the test animals were incorrectly sexed, resullting in 8-12 mice per sex per dose group.
- Control animals:
- other: One control group received de-ionised water and a low fluoride diet. One control group received sodium chloride and a low fluoride diet. An additional control group received standard diet.
- Details on study design:
- Groups of 8-12 mice of each sex received 0, 10, 30, 100, 200, 300 or 600 ppm sodium fluoride in deionised water ad libitum for 6 months. All test animals receiving water supplemented with sodium fluroide were provided with a low fluoride (<2.1 ppm) semisynthetic diet throughout the study. Three control groups were included in the studies of male and female mice; one received deionised drinking water and a low fluoride, semisynthetic diet, the second received sodium chloride supplemented deionized drinking water and a low fluoride, semisynthetic diet and the third received deionized water and a standard NIH-07 diet. At termination of the studies, the fluoride concentrations in urine, blood and bone were determined from samples collected from all surviving mice. Necropsy was performed on all animals, with histopathology at 300 and 600 ppm.
- Positive control:
- Not relevant
- Observations and examinations performed and frequency:
- Animals were observed twice daily for mortality and morbidity, weighed initially, once weekly and at termination. Clinical observations recorded daily. Food consumption recorded every other week for the first 13 weeks and for 1 week during each of the last 3 months. Water consumption was recorded daily.
- Sacrifice and pathology:
- Necropsy was performed on all animals, with histopathological investigation of animals at 300 and 600 ppm.
- Other examinations:
- Fluoride concentrations in bone, blood and urine measured prior to necropsy
- Statistics:
- Not reported.
- Clinical signs:
- effects observed, treatment-related
- Mortality:
- mortality observed, treatment-related
- Body weight and weight changes:
- effects observed, treatment-related
- Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- effects observed, treatment-related
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- effects observed, treatment-related
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Histopathological findings: neoplastic:
- no effects observed
- Details on results:
- CLINICAL SIGNS AND MORTALITY
Deaths occurred at 600 ppm (4 males, 9 females) and at 300 ppm (1 male). Signs of toxiicity (weakness, thin appearance, hunched posture) were seen at 600 ppm. Mice at 100, 200m 300 and 600 ppm had chalky white teeth; the lower incisors were more affected and were also chipped at higher dose levels.
BODY WEIGHT AND WEIGHT GAIN
Reduced weight gain was seen at 200, 300 and 600 ppm; food consumption was reduced in males at 600 ppm. Water consumption was unaffected by treatment.
GROSS PATHOLOGY
None
HISTOPATHOLOGY
Treatment-related findings were noted in the kidney, liver, testes and myocardium of decedents. Acute nephrosis was characterised by extensive multifocal degeneration and tubular necrosis and was diagnosed as the cause of death in these animals. Multifocal myocardial degeneration was also seen in two 600 ppm females. Liver changes consisted of scattered heptocellular hypertrophy and megalocytosis. The effects on the testes (degeneration/necrosis of the seminiferous tunules) were not considered to be directly related to treatment, but occur frequently in moribund mice. Effects were also noted on teh femur and (to a lesser extent) the tibia of mice at 50 ppm and greater. Changes are considered to be indicative of altered rates of bone deposition and remodelling. Effects on the teeth were seen at 300 and 600 ppm.
OTHER FINDINGS
The fluoride content of plasma, bone and urine increased with dose level. - Dose descriptor:
- NOEL
- Effect level:
- < 1.93 mg/kg bw/day (actual dose received)
- Based on:
- element
- Remarks:
- fluoride
- Sex:
- male
- Basis for effect level:
- other: Effects on bone
- Remarks on result:
- other: Corresponding NaF concentration in the water: 50 ppm
- Dose descriptor:
- NOEL
- Effect level:
- < 4.3 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Remarks:
- NaF
- Sex:
- male
- Basis for effect level:
- other: Effects on bone
- Dose descriptor:
- LOEL
- Effect level:
- 1.93 mg/kg bw/day (actual dose received)
- Based on:
- element
- Remarks:
- fluoride
- Sex:
- male
- Basis for effect level:
- other: Effects on bone
- Remarks on result:
- other: Corresponding NaF concentration in the water: 50 ppm
- Dose descriptor:
- LOEL
- Effect level:
- 4.3 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Remarks:
- NaF
- Sex:
- male
- Basis for effect level:
- other: Effects on bone
- Dose descriptor:
- NOEL
- Effect level:
- 2.89 mg/kg bw/day (actual dose received)
- Based on:
- element
- Sex:
- female
- Basis for effect level:
- other: Effects on bone
- Remarks on result:
- other: Corresponding NaF concentration in the water: 50 ppm
- Dose descriptor:
- NOEL
- Effect level:
- 6.4 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Remarks:
- NaF
- Sex:
- female
- Basis for effect level:
- other: Effects on bone
- Critical effects observed:
- not specified
- Conclusions:
- Skeletal effects of fluoride were seen at all dose levels in this study.
- Executive summary:
In the 6 month studies in mice, 4/9 males and 9/11 females receiving 600 ppm sodium fluoride and 1/8 male given water containing 600 ppm died.
The fluoride content of urine and bone increased with the concentration of sodium fluoride in the drinking water in both sexes of mice. Bone fluoride concentration were as high as 14.8 µg/mg of ashed bone in male mice receiving 600 ppm sodium fluoride in water. The bone fluoride content found in mice was somewhat greater than that found in rats given comparable sodium fluoride content. This maybe due to a greater water intake on a body weight basis by mice than by rats resulting in higher exposures. Plasma fluoride concentrations in mice showed a good dose relationship and appeared increased in groups receiving water concentrations of 50 ppm of sodium fluoride or higher.
Histopathologic findings for mice are consistent with previously recognised toxic effects. The acute nephrosis observed in the kidneys was probably the most likely cause of death. Lesions were also observed on the incisor teeth, femur and tibia of mice.
Based on these observations, the LOEL in male mice is 50 ppm NaF and the NOEL in female mice is 50 ppm NaF. Taking into account the typical water consumption, this corresponds to a LOEL of 1.93 mg F- /kg bw/d or 4.3 mg NaF/kg bw/d for male mice and a NOEL of 2.89 mg F-/kg bw/d or 6.4 mg NaF/kg bw/d for female mice.
Reference
Dose (ppm) |
Survival |
Mean Body Weight |
Final Weight relative to control (%) |
||
Initial |
Final |
Change |
|||
Male |
|||||
Controla |
9/9 |
16.9±0.4 |
40.2±1.0 |
23.3±1.1 |
100 |
Controlb |
10/10 |
18.6±0.4* |
41.6±0.6 |
23.0±0.7 |
103 |
Controlc |
11/11 |
17.8±0.4 |
39.2±1.0 |
21.4±1.0 |
97 |
10 |
9/9 |
17.3±0.5 |
43.1±1.5 |
25.8±1.8 |
107 |
50 |
10/10 |
18.0±0.6 |
41.1±1.1 |
23.1±1.3 |
102 |
100 |
10/10 |
19.2±0.8 |
41.5±1.1 |
22.3±1.3 |
103 |
200 |
10/10 |
17.9±0.7 |
36.5±1.2 |
18.6±1.4* |
91 |
300 |
7/8 |
18.8±0.7 |
38.1±1.1 |
19.0±1.4* |
95 |
600 |
5/9 |
17.4±0.4 |
32.0±1.6** |
14.8±1.9** |
80 |
Female |
|||||
Controla |
11/11 |
16.9±0.6 |
30.2±1.4 |
13.3±1.6 |
100 |
Controlb |
10/10 |
18.6±0.4 |
31.5±1.0 |
12.9±1.1 |
104 |
Controlc |
9/9 |
16.6±0.2 |
28.7±0.9 |
12.1±0.8 |
95 |
10 |
11/11 |
17.1±0.4 |
29.6±1.1 |
12.5±1.1 |
98 |
50 |
10/10 |
16.4±0.3 |
32.2±1.1 |
15.8±1.2 |
107 |
100 |
10/10 |
17.2±0.4 |
30.6±1.5 |
13.4±1.4 |
101 |
200 |
10/10 |
17.2±0.4 |
25.3±0.6** |
8.1±0.7* |
84 |
300 |
12/12 |
16.9±0.3 |
26.2±0.8* |
9.3±0.7* |
87 |
600 |
2/11 |
16.6±0.4 |
24.5±1.5 |
9.0±1.0 |
81 |
*Significantly different (P≤0.05) from the control group by Dunn’s or Shirley’s test
**P<0.01
a Control group receiving semisynthetic, low fluoride diet and deionised water.
b Control group receiving semisynthetic, low fluoride diet and sodium chloride supplemented deionised water
c Control group receiving standard NIH-07 diet and deionised water.
Organs and Diagnoses |
300 ppm |
600 ppm |
Male Animals initially in study Early deaths
Kidney Nephrosis, multifocal
Liver Megalocytosis, multifocal Syncytial alteration, multifocal
Myocardium Mineralization, multifocal
Testis Necrosis Tubule, degeneration, multifocal Tubule, multinucleated giant cells, multifocal
Female
Animals initially in study Early deaths
Kidney Nephrosis, multifocal
Liver Megalocytosis, multifocal Syncytial alteration, multifocal
Myocardium Degeneration, multifocal Mineralization, multifocal |
8 1
1
1 1
1
1
1
12 0
0
0 0
0 0 |
9 4
2
4 4
4
3 2 1
11 9
2
7 7
2 4 |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LOAEL
- 1.2 mg/kg bw/day
- Study duration:
- subchronic
- Species:
- mouse
- Quality of whole database:
- Reliable read across data based on sodium fluoride investigations.
- System:
- musculoskeletal system
- Organ:
- bone
- tooth
Repeated dose toxicity: inhalation - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: inhalation - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - local effects
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Additional information
Oral studies
In a study using 12 paired groups of albino rats, Lawrenz et al (1939) administered fluoride in the form of calcium fluoride or cryolite in the drinking water for 14 weeks. Total fluoride intake (from the basal diet and drinking water) amounted to a dose level of approximately 0.75 mg/kg bw/d, which corresponds to 1.54 mg CaF2/kg bw/d. Bodyweight gain and food consumption were retarded in both dose groups. Clinical signs were limited to transient haematuria in both groups, and the appearance of dental striations in all animals from Week 8 -10. Analytical determinations at necropsy revealed fluoride retention of approximately 59%, and that the large majority of the fluoride in the body was present in the skeleton (~96%). No differences were apparent between the treated groups. The authors conclude that the effects of fluoride from these two insoluble salts are comparable.
Smith & Leverton (1934) investigated the comparative toxicity of various forms of inorganic fluoride in a 6-week feeding study in male rats. They noted that overt effects of calcium difluoride toxicity (bodyweight reduction, mortality) were seen only at very high concentrations compared to other, water-soluble fluorides. Mortality was observed at fluoride concentrations well above 1000 mg/kg bw/d. In contrast, mild dental effects were seen at comparable fluoride levels for all of the compounds investigated, however the more severe effects were only seen at much comparatively much higher concentrations of calcium difluoride. The results of the study therefore indicate that the toxicity of calcium difluoride is markedly influenced by its low water solubility.
Sodium fluoride studies
The much greater water solubility of sodium fluoride (41300 mg/L) compared to calcium fluoride (15 mg/L) means that the bioavailability of fluoride from NaF is likely to be much greater than that of fluoride from CaF2 and therefore represents a worst case.
The toxicity of NaF has been extensively examined under the American National Toxicology Program (NTP). The dataset contains a 14 day dose range-finder test in rat and in mice, a 6 month study in rat and in mice and a 2 year chronic study in rat and in mice. The chronic data are entered in IUCLID under the carcinogenicity endpoint. The animals were administered with NaF via the drinking water.
In the 14-day range finder study in rat, mortality was seen at the highest dose level of 800 ppm, and at lower NaF concentrations, effects of reduced body weight gain were observed. Based on these findings, the registrants have deduced a NOAEL of 50 ppm NaF for male rats and 100 ppm NaF for female rats. Based on estimated water uptake information, this corresponds to ca. 4.8 mg NaF/kg bw/d for male rats and 11.3 mg NaF/kg bw/d for female rats.
In the 14-day range finder study in mice, similar observations were made, with mortality only at the highest dose level of 800 ppm and body weight changes and reduced water consumption at lower dose levels. Based on these findings, the registrants have deduced a NOAEL of 400 ppm NaF for male and female mice. Based on estimated water uptake information, this corresponds to ca. 50.2 mg NaF/kg bw/d for male mice and 76.0 mg NaF/kg bw/d for female mice.
In the 6-month rat study, reduced body weights and reduced food and water consumption were observed at the highest dose level of 300 ppm. At lower concentrations, signs of dental fluorosis were noted. Based on these findings, the registrants have deduced a NOAEL of 100 ppm NaF for male and female rats. Based on estimated water uptake information, this corresponds to ca. 5.6 mg NaF/kg bw/d for male rats and 6.7 mg NaF/kg bw/d for female rats.
In the 6-month mice study, mortality was observed at 600 ppm NaF concentration in the drinking water. At lower dose levels, skeletal effects were seen. Based on these findings, the registrants have deduced a LOEL of 50 ppm NaF for male mice and a NOEL of 50 ppm NaF for female mice. Based on estimated water uptake information, this corresponds to ca. 4.3 mg NaF/kg bw/d for male mice and 6.4 mg NaF/kg bw/d for female mice.
In the 2-year rat study, dental effects were observed at all dose levels, including the lowest applied level of 25 ppm. The LOAEL was thus determined to be 25 ppm, which corresponds to 1.3 mg NaF/kg bw/d for male and female rats.
In the 2-year mice study, the NOAEL for male and female mice was determined to be 175 ppm NaF, which corredsponds to 16.7 mg NaF/kg bw/d for male mice and 18.8 mg NaF/kg bw/d for female mice.
The available studies provide a consistent picture in which fluoride toxicity results in mortality at high dose levels, and dental and skeletal effects at lower dose levels. The lowest dose level at which dental effects are observed are found in the 2 year study in rats. Here, a LOAEL of 1.3 mg NaF/kg bw/d is determined. Taking into account that CaF2 contains 2 equivalents of fluoride per mole, this corresponds to a dose level of 1.2 mg CaF2/kg bw/d.
As mentioned before, this is to be considered a conservative estimate, as the difference in bioavailability of fluoride from CaF2 versus NaF is not accounted for.
Dermal studies
A waiver is proposed: fluoride toxicity has been adequately characterised by the oral route of exposure and dermal absorption is likely to be negligible.
Inhalation study
A waiver is proposed: fluoride toxicity has been adequatly characterised by the oral route.
Justification for selection of repeated dose toxicity via oral
route - systemic effects endpoint:
While it was necessary to use data from studies investigating sodium
fluoride toxicity, the NTP investigations into the subchronic exposure
of rats and mice are considered to be reliable and represent a worst
case for the assessment of calcium fluoride toxicity as a result of the
differing water solubility of the two salts.
Justification for selection of repeated dose toxicity inhalation -
systemic effects endpoint:
Repeated exposure guideline compliant investigation of fluoride
toxicity was considered appropriate for assessing calcium fluoride
effects
Justification for selection of repeated dose toxicity inhalation -
local effects endpoint:
Repeated exposure guideline compliant investigation of fluoride
toxicity was considered appropriate for assessing calcium fluoride
effects
Repeated dose toxicity: inhalation - systemic effects (target organ)
respiratory: lung
Justification for classification or non-classification
The available data do not indicate that the substance meets the criteria for classification for repeated dose toxicity according to the CLP Regulation (1272/2008/EC).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.